TSE:KPT KP Tissue (KPT) Stock Price, News & Analysis C$9.45 0.00 (0.00%) As of 03:59 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider TradesBuy This Stock About KP Tissue Stock (TSE:KPT) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get KP Tissue alerts:Sign Up Key Stats Today's RangeC$9.45▼C$9.5050-Day RangeC$8.77▼C$9.6952-Week RangeC$7.54▼C$9.69Volume6,750 shsAverage Volume16,229 shsMarket CapitalizationC$94.51 millionP/E Ratio21.48Dividend Yield7.62%Price TargetC$9.38Consensus RatingHold Company Overview KP Tissue Inc operates as a holding company. The firm produces, distributes, markets, and sells a range of disposable tissue products in North America. It offers bathroom and facial tissues, paper towels, paper towels, and napkins, as well as disposable wiping products and washroom dispensing systems. Read More KP Tissue Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks17th Percentile Overall ScoreKPT MarketRank™: KP Tissue scored higher than 17% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.4 / 5Analyst RatingHold Consensus RatingKP Tissue has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 3 hold ratings, and no sell ratings.Upside/DownsideThe consensus price target for KP Tissue is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageKP Tissue has only been the subject of 2 research reports in the past 90 days.Read more about KP Tissue's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of KP Tissue is 21.48, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 281.54.Price to Earnings Ratio vs. SectorThe P/E ratio of KP Tissue is 21.48, which means that it is trading at a less expensive P/E ratio than the Consumer Defensive sector average P/E ratio of about 1,078.13.Price to Earnings Growth RatioDue to a projected decrease in earnings for KP Tissue, their PEG ratio cannot be calculated.Price to Book Value per Share RatioKP Tissue has a P/B Ratio of 1.33. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for KPT. Dividend1.7 / 5Dividend StrengthWeak Dividend LeadershipKP Tissue is a leading dividend payer. It pays a dividend yield of 7.54%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthKP Tissue does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of KP Tissue is 163.64%. Payout ratios above 75% are not desirable because they may not be sustainable.Read more about KP Tissue's dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for KPT. News and Social Media2.0 / 5News SentimentN/A News SentimentKP Tissue has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.26 average news sentiment score of Consumer Defensive companies.News Coverage This WeekMarketBeat has tracked 1 news article for KP Tissue this week, compared to 1 article on an average week. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, KP Tissue insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.14% of the stock of KP Tissue is held by insiders.Percentage Held by InstitutionsOnly 1.87% of the stock of KP Tissue is held by institutions.Read more about KP Tissue's insider trading history. Receive KPT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for KP Tissue and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. KPT Stock News HeadlinesKP Tissue Earnings Call: Balanced Growth Amid ChallengesAugust 31, 2025 | tipranks.comKP Tissue Inc (TSX:KPT) Q2 2025: Everything You Need To Know Ahead Of EarningsAugust 14, 2025 | finance.yahoo.comPrepare for the “Mar-a-Lago Accord” Money ShockWhy Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for your money than tariffs is unfolding behind the scenes... Tucked inside this overlooked directive is a plan set to be executed for the first time in in U.S. history. One Stansberry Research's Senior Partner says it's set to trigger a rare window for potentially explosive gains in ONE asset immediately. (Not AI or crypto). Wall Street insiders are already positioning themselves... and he insists you should, too, before it's too late.September 18 at 2:00 AM | Stansberry Research (Ad)KP Tissue Reports Strong Q2 2025 Results and Announces Memphis InvestmentAugust 13, 2025 | msn.comKP Tissue Inc.: KP Tissue Releases Second Quarter 2025 Financial ResultsAugust 13, 2025 | finanznachrichten.deAn 8% Dividend Stock Paying Cash Every Single MonthJuly 31, 2025 | msn.comKP Tissue Inc. (KPT.TO) - Yahoo FinanceJuly 1, 2025 | ca.finance.yahoo.comWho Owns KP Tissue Inc? KPT Shareholders - Investing.comJune 26, 2025 | investing.comSee More Headlines KPT Stock Analysis - Frequently Asked Questions How have KPT shares performed this year? KP Tissue's stock was trading at C$8.23 at the beginning of 2025. Since then, KPT stock has increased by 14.8% and is now trading at C$9.45. How do I buy shares of KP Tissue? Shares of KPT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of KP Tissue own? Based on aggregate information from My MarketBeat watchlists, some other companies that KP Tissue investors own include Constellation Software (CSU), Intact Financial (IFC), AutoCanada (ACQ), Alimentation Couche-Tard (ATD.B), AbbVie (ABBV), Wheaton Precious Metals (WPM) and Vermilion Energy (VET). Company Calendar Ex-Dividend for 7/15 Dividend6/30/2025Record date for 7/15 Dividend7/15/2025Dividend Payable7/15/2025Today9/18/2025Record date for 10/15 Dividend9/30/2025Dividend Payable10/15/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE SectorConsumer Defensive Industry Household & Personal Products Sub-IndustryN/A Current SymbolTSE:KPT CIKN/A Webkptissueinc.com Phone+1-905-8126900FaxN/AEmployeesN/AYear FoundedN/APrice Target and Rating Average Price Target for KP TissueC$9.38 High Price TargetC$10.00 Low Price TargetC$8.50 Potential Upside/Downside-1.3%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)C$0.44 Trailing P/E Ratio21.59 Forward P/E Ratio21.60 P/E Growth-0.88Net IncomeC$6.38 million Net MarginsN/A Pretax MarginN/A Return on Equity9.05% Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio1.03 Quick Ratio1.23 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueC$7.08 per share Price / Book1.34Miscellaneous Outstanding Shares10,001,000Free FloatN/AMarket CapC$95.01 million OptionableNot Optionable Beta0.19 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report This page (TSE:KPT) was last updated on 9/18/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredPrepare for the “Mar-a-Lago Accord” Money ShockWhy Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for you...Stansberry Research | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding KP Tissue Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share KP Tissue With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.